Prescription drug · NDA
Emend (Fosaprepitant dimeglumine) NDC 0006-3061
Fosaprepitant dimeglumine 150 mg/5mL · Injection, Powder, Lyophilized, For solution · Intravenous · Merck Sharp & Dohme LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0006-3061-00 | 0000630610000006306100 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0006-3061-00) / 5 mL in 1 VIAL, SINGLE-DOSE (0006-3061-01)Marketed from Feb 3, 2017 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Emend
- Generic name (nonproprietary)
- fosaprepitant dimeglumine
- Active ingredients
- Fosaprepitant dimeglumine — 150 mg/5mL
- Dosage form
- Injection, Powder, Lyophilized, For solution
- Route
- Intravenous
- Labeler
- Merck Sharp & Dohme LLCNDC labeler code 0006
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 022023
- Marketing start
- Listing expires
- Other FDA classes
- Cytochrome P450 2C9 Inducers (Mechanism)Cytochrome P450 3A4 Inducers (Mechanism)Cytochrome P450 3A4 Inhibitors (Mechanism)Neurokinin 1 Antagonists (Mechanism)
- Identifiers
- Product ID 0006-3061_20906e8e-8a3e-4c45-a657-6d4c1945af09SPL ID 20906e8e-8a3e-4c45-a657-6d4c1945af09SPL set ID 8d66803a-6811-4c29-9c57-e16acfa87f21RxCUI 1731077, 1731082UNII D35FM8T64XUPC 0300063061001
- Pharmacologic class
- Substance P/Neurokinin-1 Receptor Antagonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N400006306100followed by a unit qualifier and the quantityPackage 00006-3061-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
EMEND ® for injection, in combination with other antiemetic agents, is indicated in adults and pediatric patients 6 months of age and older for the prevention of: acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy (HEC) including high-dose cisplatin. delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy (MEC). EMEND for injection is a substance P/neurokinin-1 (NK 1 ) receptor antagonist, indicated in adults and pediatric patients 6 months of age and older, in combination with other antiemetic agents, for the prevention of ( 1 ): acute and delayed nausea and vom…
Excerpt only. Read the full label for complete information.
About NDC 0006-3061
- What is NDC 0006-3061?
- 0006-3061 is the product NDC for Emend (fosaprepitant dimeglumine), Fosaprepitant dimeglumine 150 mg/5mL injection, powder, lyophilized, for solution, listed with the FDA by Merck Sharp & Dohme LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Emend (Fosaprepitant dimeglumine).
- What is the active ingredient?
- Fosaprepitant dimeglumine.
- Who is the labeler?
- Merck Sharp & Dohme LLC, NDC labeler code 0006. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Emend?
- 5 other product NDCs are listed under this name. See all Emend NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Emend products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Emendaprepitant | Aprepitant 125 mg/1 | Powder, For suspensionOral | Merck Sharp & Dohme LLC | 0006-3066 | 00006-3066-03 |
| Emendaprepitant | Aprepitant 80 mg/1 | CapsuleOral | Merck Sharp & Dohme LLC | 0006-0461 | 00006-0461-0200006-0461-12 |
| Emendaprepitant | Aprepitant 125 mg/1 | CapsuleOral | Merck Sharp & Dohme LLC | 0006-0462 | — |
| Emendaprepitant | Aprepitant 40 mg/1 | CapsuleOral | Merck Sharp & Dohme LLC | 0006-0464 | — |
| Emendaprepitant | — | Kit | Merck Sharp & Dohme LLC | 0006-3862 | 00006-3862-0300006-3862-13 |